hrcak mascot   Srce   HID

Izvorni znanstveni članak

Treatment of Ocular Motility Disturbances in Graves' Disease with Botulinum Toxin A

Neda Stiglmayer
Mladen Lešin
Jelena Juri
Milan Ivanišević
Lovro Boić
Veljko Rogošić

Puni tekst: engleski, pdf (93 KB) str. 41-46 preuzimanja: 490* citiraj
APA 6th Edition
Stiglmayer, N., Lešin, M., Juri, J., Ivanišević, M., Boić, L. i Rogošić, V. (2005). Treatment of Ocular Motility Disturbances in Graves' Disease with Botulinum Toxin A. Collegium antropologicum, 29 - Supplement 1 (1), 41-46. Preuzeto s https://hrcak.srce.hr/27911
MLA 8th Edition
Stiglmayer, Neda, et al. "Treatment of Ocular Motility Disturbances in Graves' Disease with Botulinum Toxin A." Collegium antropologicum, vol. 29 - Supplement 1, br. 1, 2005, str. 41-46. https://hrcak.srce.hr/27911. Citirano 29.07.2021.
Chicago 17th Edition
Stiglmayer, Neda, Mladen Lešin, Jelena Juri, Milan Ivanišević, Lovro Boić i Veljko Rogošić. "Treatment of Ocular Motility Disturbances in Graves' Disease with Botulinum Toxin A." Collegium antropologicum 29 - Supplement 1, br. 1 (2005): 41-46. https://hrcak.srce.hr/27911
Harvard
Stiglmayer, N., et al. (2005). 'Treatment of Ocular Motility Disturbances in Graves' Disease with Botulinum Toxin A', Collegium antropologicum, 29 - Supplement 1(1), str. 41-46. Preuzeto s: https://hrcak.srce.hr/27911 (Datum pristupa: 29.07.2021.)
Vancouver
Stiglmayer N, Lešin M, Juri J, Ivanišević M, Boić L, Rogošić V. Treatment of Ocular Motility Disturbances in Graves' Disease with Botulinum Toxin A. Collegium antropologicum [Internet]. 2005 [pristupljeno 29.07.2021.];29 - Supplement 1(1):41-46. Dostupno na: https://hrcak.srce.hr/27911
IEEE
N. Stiglmayer, M. Lešin, J. Juri, M. Ivanišević, L. Boić i V. Rogošić, "Treatment of Ocular Motility Disturbances in Graves' Disease with Botulinum Toxin A", Collegium antropologicum, vol.29 - Supplement 1, br. 1, str. 41-46, 2005. [Online]. Dostupno na: https://hrcak.srce.hr/27911. [Citirano: 29.07.2021.]

Sažetak
The aim of this study was to evaluate the efficacy of botulinum toxin-A injections on motility disturbance in patients
with dysthyroid eye disease. In 36 patients (52 orbits) with active phase of Grave’s ophthalmopathy with motility disturbance,
botulinum toxin-A injections were applied. Ocular motility was measured before and after treatment in four
main directions (elevation, depression, abduction and adduction) with Förster perimeter. In all patients 20 units of
botulinum toxin-A in one single injection was applied in the projection of the inferior rectus muscle. Statistically, the
degree of upgaze increased notably in all three groups, but mostly in the first group where it amounted up to 5.8–6.0
(z=10.0; p=0.68). We could not prove notable increase of the motility grade in the adduction in none of the groups of the
tested patients. Due to the fact that eyeball motility can be objectively measured, effect of the applied therapy can be
clearly evaluated.

Ključne riječi
Graves' disease; dysthyroid orbitopathy; botulinum toxin-A; motility disturbance

Hrčak ID: 27911

URI
https://hrcak.srce.hr/27911

Posjeta: 656 *